Imatinib plasma levels and clinical features of successful long-term treatment of metastatic gastrointestinal stromal tumors

被引：0
|
作者：
Sawaki, A. [1 ]
Yamamura, M. [1 ]
Katata, Y. [1 ]
Okawaki, M. [1 ]
Yamaguchi, Y. [1 ]
Hirai, T. [2 ]
机构：
[1] Kawasaki Med Sch, Med Oncol, Kurashiki, Okayama, Japan
[2] Kawasaki Med Sch, Digest Surg, Kurashiki, Okayama, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
364P
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [41] Long-term efficacy of imatinib for treatment of metastatic GIST
    Shreyaskumar Patel
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 277 - 286
  • [42] Long-term survival of a cat with a metastatic gastrointestinal stromal tumor
    Civa, Patrick Antonio Sonaglio
    Fonseca-Alves, Carlos Eduardo
    Dos Anjos, Denner Santos
    JOURNAL OF FELINE MEDICINE AND SURGERY OPEN REPORTS, 2024, 10 (01):
  • [43] Update on imatinib for gastrointestinal stromal tumors: duration of treatment
    Linch, Mark
    Claus, Jeroen
    Benson, Charlotte
    ONCOTARGETS AND THERAPY, 2013, 6 : 1011 - 1023
  • [44] What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib?
    Piotr Rutkowski
    Jolanta Andrzejuk
    Elżbieta Bylina
    Czesław Osuch
    Tomasz Świtaj
    Anna Jerzak vel Dobosz
    Urszula Grzesiakowska
    Monika Jurkowska
    Agnieszka Woźniak
    Janusz Limon
    Maria Dębiec-Rychter
    Janusz A. Siedlecki
    Medical Oncology, 2013, 30
  • [45] What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib?
    Rutkowski, Piotr
    Andrzejuk, Jolanta
    Bylina, Elzbieta
    Osuch, Czeslaw
    Switaj, Tomasz
    vel Dobosz, Anna Jerzak
    Grzesiakowska, Urszula
    Jurkowska, Monika
    Wozniak, Agnieszka
    Limon, Janusz
    Debiec-Rychter, Maria
    Siedlecki, Janusz A.
    MEDICAL ONCOLOGY, 2013, 30 (04)
  • [46] Impact of mutational status on long-term treatment outcomes in patients with advanced gastrointestinal stromal tumors (GIST) treated in the first line with imatinib
    Sobczuk, P.
    Bylina, E.
    Klimczak, A.
    Rutkowski, P.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1238 - S1238
  • [47] Clonal evolution of resistance to imatinib in patients with metastatic gastrointestinal stromal tumors
    Desai, Jayesh
    Shankar, Sridhar
    Heinrich, Michael C.
    Fletcher, Jonathan A.
    Fletcher, Christopher D.
    Manola, Judi
    Morgan, JeffreyA.
    Corless, Christopher L.
    George, Suzanne
    Tuncali, Kemal
    Silverman, Stuart G.
    Van den Abbeele, Annick D.
    van Sonnenberg, Eric
    Demetri, George D.
    CLINICAL CANCER RESEARCH, 2007, 13 (18) : 5398 - 5405
  • [48] Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors
    De Giorgi, U
    Aliberti, C
    Benea, G
    Conti, M
    Marangolo, M
    CLINICAL CANCER RESEARCH, 2005, 11 (17) : 6171 - 6176
  • [49] Effect of long term imatinib on bone in adults with chronic myelogenous leukemia and gastrointestinal stromal tumors
    Berman, Ellin
    Girotra, Monica
    Cheng, Catherine
    Chanel, Suzanne
    Maki, Robert
    Shelat, Meenakshi
    Strauss, H. William
    Fleisher, Martin
    Heller, Glenn
    Farooki, Azeez
    LEUKEMIA RESEARCH, 2013, 37 (07) : 790 - 794
  • [50] Gastrointestinal stromal tumors : clinical features and diagnosis
    Landi, Bruno
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2012, 196 (4-5): : 845 - 853
12345